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SUMMARY
The recent discovery of the positive-sense single-
stranded RNA (ssRNA) Orsay virus (OV) as a natural
pathogen of the nematode Caenorhabditis elegans
has stimulated interest in exploring virus-nematode
interactions. However, OV infection is restricted to
a small number of intestinal cells, even in nematodes
defective in their antiviral RNA interference (RNAi)
response, and is neither lethal nor vertically trans-
mitted. Using a fluorescent reporter strain of the
negative-sense ssRNA vesicular stomatitis virus
(VSV), we show that microinjection of VSV particles
leads to a dose-dependent, muscle tissue-tropic, le-
thal infection in C. elegans. Furthermore, we find
nematodes deficient for components of the antiviral
RNAi pathway, such as Dicer-related helicase 1
(DRH-1), to display hypersusceptibility to VSV infec-
tion as evidenced by elevated infection rates, virus
replication in multiple tissue types, and earlier mor-
tality. Strikingly, infection of oocytes and embryos
could also be observed in drh-1mutants. Our results
suggest that the antiviral RNAi response not only in-
hibits vertical VSV transmission but also promotes
transgenerational inheritance of antiviral immunity.
Our study introduces a new, in vivo virus-host model
system for exploring arbovirus pathogenesis and
provides the first evidence for vertical pathogen
transmission in C. elegans.
INTRODUCTION
Genetic tractability, ease of culture, and susceptibility to a variety
of bacterial and fungal pathogens [1, 2] have made C. elegans
attractive for exploring microbe-host interactions. However,
due to a lack of convenient experimental systems, relatively
few studies have explored virus-C. elegans interactions. Initial
studies investigating virus-C. elegans interactions used primary
cell cultures and defined an antiviral role for the nematode
RNA interference (RNAi) response [3, 4].
RNAi is a highly conserved mechanism of gene silencing
that contributes to antiviral defense in insects [5], plants [6], and
mammals [7, 8]. In C. elegans, the antiviral RNAi response is
initiated after recognition and cleavage of viral double-stranded
RNAs by a complex consisting of Dicer-related helicase 1
(DRH-1), DCR-1, and RDE-4 into 23-nt-long primary small inter-
fering RNAs (siRNAs) [9]. These duplex siRNAs are then loaded
into the primary Argonaute protein RDE-1 and one strand of
the duplex is lost. These RDE-1-primary siRNA complexes then
recruit RNA-dependent RNA polymerase complexes to viral
RNA targets, where they generate secondary siRNAs termed
‘‘22Gs,’’ which are typically 22 nt long and contain 50 guanines
[10, 11]. These 22Gs then complex with, and guide, secondary
Argonautes to complementary viral single-strandedRNA (ssRNA)
targets (e.g., mRNAs or genomes), resulting in Argonaute-medi-
ated target cleavage and inhibition of virus replication [9].
Despite initial insights into virus-C. elegans interactions pro-
vided by primary cell-culture studies, these cultures have limited
utility because they are technically challenging to generate and
may not be representative of infection in animals. To investigate
virus-C. elegans interactions in vivo, Lu et al. created a nematode
strain encoding a flock house virus replicon [12]. Although this re-
plicon system has identified host factors, such as DRH-1 [13],
that restrict virus replication, it cannot identify nematode factors
influencing aspects of the viral life cycle that would only be
afforded with a bona fide viral pathogen (e.g., transmission,
entry, exit, etc.) [14].
More recently, the positive-sense ssRNA Orsay virus (OV) was
described as a natural pathogen ofC. elegans [14]. The discovery
of OV represents an important step in defining virus-nematode
interactions; however, this model also possesses limitations.
First, OV infection is limited to one to six intestinal cells, even
during infection of RNAi-deficient animals [15]. Therefore, identi-
fying antiviral factors specific to non-intestinal tissues with the
OV model may be difficult. Second, because OV infection is not
lethal [14], scoring the minor pathological features of infection
can be challenging. Third, recombinant OV strains expressing
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Figure 1. Microinjection of AdultC. elegansAnimals with Recombinant VSV Expressing dsREDResults in an Infection Primarily Restricted to
Muscle Tissue
(A) Differential interference contrast (DIC) and fluorescencemicrographs (103magnification) of N2 adults either mock or VSV-dsRED infected. Imageswere taken
72 hr post-infection (hpi). Green fluorescence indicates autofluorescence signal in the intestine.
(B) Fluorescence micrographs (103 magnification) of a psng-1::LUC-GFP adult infected with VSV-dsRED 72 hpi.
(legend continued on next page)
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fluorescent or quantifiable reporter genes are unavailable,making
analysis of OV replication limited to PCR- or immunofluores-
cence-basedmethods. Finally, becauseOV is not vertically trans-
mitted [14], this model may be unsuitable for identifying immunity
mechanisms guarding against vertical transmission.
Given the shortcomings of current virus-C. elegansmodel sys-
tems, we asked whether an alternative system could be estab-
lished using the negative-sense ssRNA vesicular stomatitis virus
(VSV). VSV is a member of the arboviruses, a group of emerging
viral pathogens that are transmitted by arthropods to vertebrate
hosts. Thewide availability of reverse genetic and immunological
tools for VSV [16, 17] makes it convenient for studying arboviral
disease mechanisms relevant to human and animal health
[18, 19]. Furthermore, because VSV can replicate in C. elegans
primary cells [3, 4], we thought it possible that VSV could infect
C. elegans animals.
Here we show that microinjection of VSV particles produces a
lethal infection in C. elegans. We further show that the suscepti-
bilities of animals to infection, the tissues infected, and animal
survival are dependent upon virus dose, culturing conditions,
and host genetic background. We also establish a role for the
nematode antiviral RNAi pathway in restricting arbovirus replica-
tion and pathogenesis. Finally, we use this model to provide the
first evidence for vertical transmission in C. elegans and impli-
cate the antiviral RNAi response in both inhibiting vertical trans-
mission and promoting transgenerational inheritance of antiviral
immunity.
RESULTS
Microinjection of VSV into C. elegans Results in an
Infection Primarily Restricted to Muscle Tissue
To determine whether VSV could infect C. elegans, we microin-
jected wild-type (N2 strain) adults with a recombinant VSV strain
encoding the fluorescent reporter dsRED (VSV-dsRED) [20]. We
targeted the body cavity and intestinal tissue just posterior to the
terminal bulb of the pharynx for injections. After microinjection,
we observed a prominent dsRED signal in animals that was
both above background signals in mock-infected animals and
significantly different from autofluorescence observed in intesti-
nal tissues (Figure 1A). Microinjection of VSV-dsRED into trans-
genic animals expressing GFP under a neuronal promoter [21]
revealed only a minor overlap of GFP and dsRED signals in
head neurons (Figures 1B and 1C). However, significant overlap
in dsRED and GFP signals was observed throughout infected
transgenic animals expressing GFP under a muscle-specific
promoter [21] (Figure 1D), with clear infection of body wall mus-
cle in the head and tail (Figure 1E). We could also establish VSV-
dsRED infections in the Hawaiian isolate (CB4856) of C. elegans
(Figure S1A) and in Caenorhabditis briggsae (Figure S1B). Inter-
estingly, whereas both the N2 and Hawaiian animals displayed
infection rates of 85%–90%, only 20% of C. briggsae animals
displayed dsRED signal by 72 hr post-infection (hpi), suggesting
that C. briggsaemay be more resistant to infection (Figure S1C).
Loss of DRH-1 FunctionResults inHypersusceptibility to
Lethal VSV Infection
Previous flock house virus replicon [13] and OV [9] studies have
implicated DRH-1 in the restriction of positive-sense ssRNA vi-
rus replication inC. elegans. DRH-1 functions in a similar manner
as homologous mammalian RIG-I-like helicases (RLHs), which
sense cytosolic viral RNA signatures and subsequently trigger
antiviral response programs [9, 22]. Although mammalian RLHs
and DRH-1 both trigger an antiviral response upon viral RNA
recognition, mammalian RLHs trigger the interferon response
[23], whereas DRH-1 promotes the initiation of the C. elegans
antiviral RNAi response [9, 13].
To determine whether DRH-1 is involved in sensing negative-
sense ssRNA virus infection, we challenged animals carrying
a loss-of-function mutation in drh-1 with VSV-dsRED and
compared the dsRED pattern to N2 infections. Interestingly,
drh-1 worms displayed infection in multiple tissues not involved
in N2 infections, such as intestinal tissue (Figure 2A). To further
compare dsRED signals in N2 and drh-1 strains, we microin-
jected either a low (102 plaque-forming units [PFU]) or high
(104 PFU) dose of VSV-dsRED into either strain and then
measured signals in either whole animals (Figure 2B) or specific
tissues (Figures 2C–2F) 48 hpi. Whole-body dsRED measure-
ments indicated that drh-1 animals displayed 5- and 18-fold
higher signals than mock-infected animals at the 102 and
104 PFU doses, respectively. In contrast, dsRED signals in N2
animals were either essentially identical to or 3-fold higher
than mock-infected animals at these respective doses (Fig-
ure 2B). Measurement of dsRED signals in individual tissues
revealed a similar pattern, with drh-1 animals presenting with
4- to 10-fold higher signals at the 102 PFU dose and 17-
to 51-fold higher signals at the 104 PFU dose compared to
mock-infected animals. Significant N2 dsRED signals were typi-
cally only observed with 104 PFU treatments and were 3- to
7-fold higher than mock-infected animals. Animals were scored
as infected if their whole-body dsRED signals were at least 2-fold
higher than mock-infected animals by 48 hpi. Using this cutoff,
we found that at a dose of 104 PFU, 100% of both N2 and
drh-1 animals scored as infected. In contrast, no N2 and 80%
of drh-1 animals scored as infected in 102 PFU treatments (Fig-
ure 2G). However, when only vulval tissue dsRED signals were
used to score infection in 102 PFU treatments, 30% of N2
animals scored as infected (Figure S2), suggesting that this tis-
sue may be a more reliable indicator of low-level infections.
These results suggest that higher viral doses allow for viral repli-
cation to reach a threshold at which dsRED signals become
detectable by 48 hpi in both N2 and drh-1 strains. However, at
lower viral doses, N2 animals may bemore capable of suppress-
ing VSV-dsRED replication and hence are not scored as infected
by 48 hpi. Importantly, we confirmed that the elevated dsRED
signal observed in drh-1 animals reflected bona fide VSV tran-
scription using RT-PCR (Figure S3) [24].
To examine viral susceptibilities of N2 and drh-1 strains
further, we tracked animals that had been microinjected with
(C) Confocal microscopy fluorescence micrographs (203 magnification) of head and tail regions of a psng-1::GFP-LUC adult infected with VSV-dsRED 72 hpi.
(D) Fluorescence micrographs (103 magnification) of a pmyo-3::LUC-GFP adult infected with VSV-dsRED 72 hpi.
(E) Confocal microscopy fluorescence micrographs (203 magnification) of head and tail regions of a pmyo-3::GFP-LUC adult infected with VSV-dsRED 72 hpi.
All infections were carried out using 104 plaque-forming units (PFU) of VSV-dsRED per injection. See also Figure S1.
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102, 103, or 104 PFU of VSV-dsRED for infection rate (Figure 2H)
and survival (Figure 2I). The maximal number of infected animals
in each injected group was reached by 48 hpi, with the exception
of N2 animals injected with 102 PFU, which took until 96 hpi (Fig-
ure 2H). The 102, 103, and 104 PFU doses resulted in infection of
25%, 50%, and 85% of N2 animals, respectively. In contrast,
these doses resulted in 80%, 95%, and 100% infection rates
in drh-1 animals (Figure 2H). Given that infection rates in several
treatments never achieved 100%, it is likely that horizontal trans-
mission of VSV between adults is inefficient.
We used lifespan assays (Figure 2I) to estimate the time at
which 50% of animals in each treatment had died (expressed
as lethal time 50 [LT50] in hpi). We also calculated 95% confi-
dence intervals (CIs) for each LT50 and, in cases where 95%
CIs of two different LT50 values did not overlap, these two values
were deemed statistically different (p < 0.05). The LT50 (95% CI)
for mock-infected N2 animals (250 hpi [236–265 hpi]) was
not significantly different from mock-infected drh-1 mutants
(240 hpi [228–252 hpi]). However, both N2 and drh-1 animals
had significantly lower LT50 values when infected with VSV-
dsRED at any of the three doses used, suggesting that VSV
infection is ultimately lethal. However, N2 animals survived for
significantly longer periods of time than drh-1 animals injected
with the same viral dose. For example, at a dose of 102 PFU,
the LT50 (95% CI) for N2 animals was 220 hpi (210–228 hpi)
versus 112 hpi (104–119 hpi) for drh-1 animals. This trend was
Figure 2. Loss of DRH-1 Function Results in Enhanced Susceptibility to VSV-dsRED Infection
(A) DIC and fluorescencemicrographs (103magnification) of N2 or drh-1 adultsmock infected or infectedwith 104 PFU of VSV-dsRED. Imageswere taken 72 hpi.
Green fluorescence indicates autofluorescence obtained in the intestine.
(B–F) Mean dsRED intensity measurements for N2 or drh-1 adults (n = 10/treatment) 48 hpi using the indicated VSV-dsRED dose. Measurements were taken of
either the whole body (B) or the indicated tissues (C–F). Mean dsRED measurements for the entire group (horizontal bars) and 95% confidence intervals (error
bars) are shown.
(G) Percentage of animals displaying a whole-body dsRED signal at least 2-fold above mock-infected animals by 48 hpi.
(H) Percentage of animals (n = 20–30/treatment) displaying dsRED signal at the indicated times post-infection.
(I) Percentage of animals from (H) alive at the indicated times post-infection.
See also Figures S2 and S3.
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also observed at the 103 PFU dose, with LT50 (95%CI) for N2 an-
imals being 176 hpi (166–186 hpi) versus 121 hpi (116–127 hpi)
for drh-1 animals and at the 104 PFU dose (N2, 168 hpi [162–
Figure 3. Small RNAs Produced upon VSV-
dsRED Infection of N2 and drh-1 Animals
(A) The number of unique sequences obtained by
Illumina high-throughput small RNA sequencing
that match a given position in the VSV-dsRED
genome in infected N2 or drh-1 animals is shown.
The number of unique sequences in sense and
antisense orientation is shown on the positive
(cyan) and negative (purple) y axis, respectively.
The negative-sense ssRNA VSV-dsRED genome
(in 30-to-50 orientation) is depicted above.
(B and C) Features of sense (B) and antisense
(C) small RNAs (length and identity of the first
nucleotide) cloned from VSV-dsRED-infected N2
animals.
(D and E) Features of sense (D) and antisense (E)
small RNAs cloned from VSV-dsRED-infected
drh-1 animals.
174 hpi] versus drh-1, 106 hpi [99–
112 hpi]). These results suggest that
drh-1 animals suffer higher infection rates
and reduced survival times compared to
N2 animals.
ASmall RNAResponse IsGenerated
upon VSV Infection
We next used deep sequencing to deter-
mine whether small RNAs (17–30 nt in
length) were generated in response to
VSV-dsRED infection. Small RNAs that
mapped to the VSV-dsRED genome are
shown in Figure 3A. These RNAs were
virtually absent from uninfected animals
(data not shown). In N2 libraries, small
RNAs corresponding to the antisense (or
genomic) strand of VSV-dsRED were
29-fold more abundant than those map-
ping to the sense (antigenomic) strand
(Figures 3B and 3C). Both antisense and
sense RNAs were characterized by a
peak length of 22 nt and a strong prefer-
ence for G at their 50 ends, and thus
likely represent 22Gs. Consistent with a
defect in the initiation of an antiviral
RNAi response, 4-fold fewer viral small
RNAs were detected in drh-1 animals
than in N2 infections. Furthermore,
although both antisense and sense small
RNAs from drh-1 animals also displayed
a bias for 50 G residues, a clear 22 nt
peak length was only observed among
antisense small RNAs (Figures 3D and
3E). In addition, drh-1 antisense small
RNAs were only 2-fold more abundant
than sense RNAs. These results suggest
that both N2 and drh-1 animals raise a small RNA response to
VSV-dsRED infection but that drh-1 animals may be impaired
in generating antisense small RNAs.
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Development of a Luciferase Assay for VSV Replication
in C. elegans
To further characterize VSV infection dynamics, we created a
simple, quantitative assay to assess VSV replication. To do
this, we employed a recombinant VSV strain encoding a firefly
luciferase (LUC) gene under a viral promoter (VSV-LUC [25])
along with chemiluminescent LUC assays to measure VSV
gene expression. LUC activity detected from VSV-LUC infec-
tions closely mirrors virion production and serves as a conve-
nient and sensitive assay for virus production [24]. To test the
utility of these assays, we microinjected groups of N2 or drh-1
animals with VSV-LUC and collected equal numbers of animals
at various times post-infection. Although light unit (LU) signals
from infected N2 animals were 600-fold higher than from
mock-infected animals by 24 hpi, these signals only increased
by 2-fold by 72 hpi (Figure 4A). In contrast, LU signals from
VSV-LUC-infected drh-1 animals were 8,800-fold higher than
from mock-infected animals by 24 hpi and these signals
increased by 7-fold by 72 hpi. Trends observed in LUC assays
were further confirmed by immunoblotting (Figure 4B). Although
we were unable to detect LUC protein from infected N2 lysates,
we did detect a small amount of VSV Matrix structural protein
(Figure 4B). In contrast, abundant LUC and Matrix proteins
were detected in VSV-LUC-infected drh-1 lysates (Figure 4B).
Collectively, these data show that LUC assays provide a sensi-
tive and convenient method to assess VSV replication in
C. elegans.
VSV Replication and Infection and Mortality Rates Are
Temperature Dependent
To determine whether temperature influences VSV replica-
tion, we measured LU signals from VSV-LUC-infected animals
Figure 4. Characterization of the Effects of Nematode Culturing Temperature and Host Genetic Background on VSV Replication and Host
Survival
(A) Luciferase (LUC) assay (in arbitrary light units, LUs) of adult animals (n = 15/treatment/experiment) infected with 104 PFU of VSV-LUC. LUs detected from
infected animals were divided by the LUs obtained from mock-infected animals of the same strain. Data represent means (±SEM).
(B) Immunoblot of lysates from (A) for LUC, VSV Matrix (M), and cellular actin proteins. The asterisk indicates a non-specific band in the actin immunoblot.
(C) LUC assay of lysates from adult animals (n = 10/treatment/experiment) infected with 104 PFU of VSV-LUC and cultured at the indicated temperatures until
72 hpi. Data represent means (±SEM), and asterisks indicate treatments that are significantly different (p < 0.05) from 15C treatments within strains.
(D) Percentage of animals (n = 20–30/treatment) displaying dsRED signal at the indicated times post-infection with 104 PFU of VSV-dsRED.
(E) Percentage of animals from (D) alive at the indicated times post-infection.
(F) LUC assay of lysates from adult animals (n = 10/treatment/experiment) infected with 104 PFU of VSV-LUC until 72 hpi. LUs detected from infected animals
were divided by LUs obtained from mock-infected N2 animals. Data represent means (±SEM), and asterisks indicate treatments that are significantly different
(p < 0.05) from N2 treatments.
(G) Percentage of animals (n = 20–30/treatment) displaying dsRED signal at the indicated times post-infection with 104 PFU of VSV-dsRED.
(H) Percentage of animals from (G) alive at the indicated times post-infection.
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cultured at 15C, 20C, or 25C. LU signals were significantly
higher when either N2 or drh-1 animals were cultured at 25C
as compared to 15C (p < 0.05). Although not statistically
different, LU signals from 20C incubations trended toward be-
ing higher than signals from 15C incubations (Figure 4C).
To investigate whether temperature affected infection or mor-
tality rates, we challenged animals with VSV-dsRED and then
monitored animals for infection (Figure 4D) and survival (Fig-
ure 4E). Interestingly, incubation temperatures appeared to
affect both the maximum percentage of animals infected and
the timing of when these values were reached. For example,
use of 15C, 20C, and 25C incubation temperatures resulted
in maximal infection rates of 38%, 72%, and 84% of N2 animals
by 120, 72, and 48 hpi, respectively (Figure 4D). A similar trend
was observed for drh-1 animals (albeit with higher infection
rates) such that 91%, 95%, and 100% of animals incubated at
15C, 20C, and 25C scored as infected by 96, 48, and
24 hpi, respectively (Figure 4D).
Examination of survival rates suggested that LT50 values
decrease with increasing temperature (Figure 4E). For example,
LT50 (95% CI) values for infected N2 animals cultured at 15
C
(408 hpi [403–413 hpi]), 20C (384 hpi [380–388 hpi]), and 25C
(124 hpi [116–131 hpi]) were all significantly different from one
another. The LT50 (95% CI) values for infected drh-1 animals
cultured at 15C (257 hpi [239–274 hpi]), 20C (191 hpi [177–
205 hpi]), and 25C (94 hpi [86–101 hpi]) also decreased with
increasing temperature. Collectively, these results suggest that
VSV replication and infection rates increase with increasing tem-
perature, whereas animal survival rates decrease.
Downstream Components of the Antiviral RNAi Pathway
Are Also Required to Restrict VSV Infection
Wenext wanted to examinewhether strains with loss-of-function
mutations in other RNAi pathway components display VSV
hypersusceptibility. Using our LUC-based assays for viral repli-
cation, we found that, in addition to drh-1 animals, the RNAi-
defective strains rde-1 [26] and rde-4 [26] also displayed
significantly higher (p < 0.05) VSV-LUC replication than N2 ani-
mals (Figure 4F), suggesting that these downstream compo-
nents are also required to restrict viral replication. Although LU
signals in RNAi-defective C04F12.1 mutants [27] were 8-fold
higher than in N2 animals, these values did not reach statistical
significance (p = 0.1). Furthermore, strains deficient for SID-1
(required for systemic spreading of exogenous RNAi signals
[28]), ALG-1 and ALG-2 (Argonautes involved in the microRNA
pathway [29]), and PRG-1 (an Argonaute required for the Piwi-in-
teracting RNA pathway [30]) did not display altered VSV-LUC
susceptibilities (p > 0.05).
We next asked whether the enhanced viral replication
observed in rde-1 animals correlated with increased infection
rates and reduced survival rates. Whereas only 85% of N2 ani-
mals scored positive for infection, all drh-1 and rde-1 animals
displayed dsRED signal by 48 hpi (Figure 4G). Furthermore, the
LT50 (95% CI) values for both drh-1 (119 hpi [105–133 hpi]) and
rde-1 (105 hpi [90–121 hpi]) animals were significantly lower
than that of N2 animals (168 hpi [164–172 hpi]) but did not signif-
icantly differ from one another (Figure 4H). These data suggest
that RNAi pathway components downstream of DRH-1 are
also required for combating VSV infection.
DRH-1 Is Required for Full Immunity to Vertical Virus
Transmission
During our lifespan assays, we noticed that when we used nem-
atode growth medium (NGM) plates containing the DNA synthe-
sis inhibitor fluorodeoxyuridine (FUdR), dsRED-positive embryos
could often be observed with a fluorescence stereo zoommicro-
scope on plates containing VSV-dsRED-infected drh-1 animals
(Figure 5A). FUdR has been shown to induce sterility and prevent
egg hatching [31], and thus is useful when tracking adult nema-
todes over extended incubation periods. Importantly, FUdR
does not impede VSV replication [32], and thus is not expected
to directly affect viral replication. We further confirmed dsRED
signals in embryos using differential interference contrast and
fluorescence microscopy (Figure 5B). Furthermore, dsRED sig-
nals could be observed in oocytes (Figure S4A) and embryos
(Figure S4B) within infected drh-1 animals, suggesting that
VSV-dsRED was entering and infecting germline tissues. We
further confirmed VSV transcription in dsRED-positive embryos
using RT-PCR (Figure S5).
Given our inability to detect dsRED-positive embryos in our
initial experiments using normal NGM plates, we asked whether
FUdR treatment might influence vertical transmission of VSV-
dsRED. When cultured on control plates, both mock- and VSV-
dsRED-infected N2 and drh-1 animals produced a similar
number of total progeny, suggesting that there were no virus-
or strain-dependent differences. Similar results were obtained
when injected animals were cultured on FUdR plates, albeit the
total progeny sizes were reduced compared to control plates
and a greater proportion of progeny were embryos (Figure 5C).
Despite these reduced brood sizes, dsRED-positive embryos
were only detected on FUdR plates containing drh-1 animals
(Figure 5D). Because only 9% of embryos laid by infected
drh-1 animals displayed dsRED signal, we wanted to confirm
that this was not simply a ‘‘jackpot’’ event that only occurred
on drh-1 plates by chance. Therefore, we repeated these exper-
iments using larger numbers of N2 and drh-1 adults and plated
all VSV-dsRED-infected animals onto FUdR plates. Despite
similar brood sizes between N2 and drh-1 strains (Figure 5E),
dsRED-positive embryos were again only detected on drh-1
plates (Figure 5F).
Wenext askedwhether direct germline injection of VSV-dsRED
might alter eitheroverall or germline tissue-specific infection rates
in N2 or drh-1 animals after culturing animals on FUdR. Interest-
ingly, both strains displayed similar overall infection rates when
challenged by either somatic or germline VSV-dsRED injections.
In contrast, higher germline infection rates were observed when
VSV-dsRED was directly injected into the germline (as oppose
to the soma) for both N2 (0% versus 6%) and drh-1 (24% versus
74%) animals (Figure S6A). These data suggest that direct injec-
tion of VSV-dsRED particles into the germline may overwhelm
germline antiviral defenses that might otherwise be protective
when VSV-dsRED must first spread from somatic tissues.
We next asked whether FUdR was still required to observe
germline VSV-dsRED infection after direct challenge of the
germline of drh-1 animals. Strikingly, we observed similar germ-
line infection rates in animals cultured on either control or FUdR-
containing medium (Figure S6B). These data suggest that FUdR
does not influence germline infection rates when VSV-dsRED is
directly injected into the germline.
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Collectively, these results show that VSV can be vertically
transmitted to offspring, and that germline immunity to VSV
infection can be influenced by the site of injection, the presence
of FUdR in the culturing medium, and DRH-1 function.
Inheritance of Antiviral Immunity after VSV Infection
Although there is clear evidence for the transgenerational inher-
itance of RNAi responses generated by expression of foreign
transgenes or the flock house virus replicon in C. elegans
[33, 34], inheritance of antiviral RNAi responses to OV remains
controversial. Therefore, we were interested to determine
whether transgenerational immunity could be observed with
our VSV model. To address this, we collected embryos from
N2 animals that had either been mock or VSV-dsRED infected,
allowed the resultant progeny to develop to adulthood, and
then challenged these progeny with VSV-dsRED. As shown in
Figure 6A, animals whose mother was previously exposed to
VSV-dsRED exhibited a significantly lower infection rate than an-
imals whose mother had been mock infected (p < 0.01). We then
asked whether this inherited protection against infection could
also be observed in drh-1 animals. Interestingly, we found that
both N2 and drh-1 progeny animals displayed significantly
Figure 5. DRH-1 Is Required for Full Immunity to Vertical Virus Transmission
(A) Bright-field and fluorescence micrographs (1123 magnification) taken with a fluorescence stereo zoom microscope of a dsRED-positive embryo laid by an
adult drh-1 animal infected with VSV-dsRED.
(B) DIC and fluorescence micrographs (403 magnification) of dsRED-positive embryos laid by an adult drh-1 animal infected with VSV-dsRED.
(C) Mean number (±SEM) of larvae or dead embryos laid by mock- or VSV-dsRED-infected animals (n = 10 animals/treatment) 48 hpi when cultured on normal
nematode growth media (control) or media containing fluorodeoxyuridine (FUdR).
(D) Percentage of total embryos from (C) displaying dsRED signal.
(E) Mean number (±SEM) of larvae or dead embryos laid by VSV-dsRED-infected animals (n = 20 animals/treatment) 48 hpi when cultured on plates
containing FUdR.
(F) Percentage of total embryos from (E) displaying dsRED signal.
See also Figures S4–S6.
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reduced infection rates when they derived from infectedmothers
as opposed to mock-infected mothers (p < 0.05) (Figure 6B).
In C. elegans, heritable antiviral immunity is thought to be
mediated by small RNAs [34, 35], and our deep-sequencing re-
sults revealed a reduced, but not absent, small RNA response
against VSV-dsRED in drh-1 animals. Therefore, we thought it
possible that the residual small RNA response (consisting pri-
marily of 22Gs) in drh-1 animals might still be capable of medi-
ating a protective effect in resulting progeny. To address this,
we made use of animals with an inactivating mutation in the
rde-3 gene, which encodes a putative nucleotidyl transferase
required for 22G biogenesis [36, 37]. When challenged with
104 PFU of VSV-dsRED, rde-3 animals displayed hypersuscep-
tibility to infection as evidenced by infection of multiple tissues
(Figure 6C), elevated infection rates (Figure 6D), and significantly
reduced LT50 (91 versus 123 hpi) values compared to N2 animals
(Figure 6E). Higher infection rates of rde-3 animals were not only
observed with higher doses (104 PFU) but also at lower doses
(102 PFU), further confirming the hypersusceptibility of rde-3
animals to infection (Figure 6F). We then performed transgenera-
tional immunity assays with N2 and rde-3 animals in which
progeny frommock- or VSV-dsRED-infectedmothers were chal-
lengedwith either 102 or 104 PFU of VSV-dsRED and then scored
for infection 72 hr later. Whereas N2 progeny derived from in-
fected mothers displayed significantly reduced infection rates
compared to those from mock-infected mothers when chal-
lenged with either low or high viral doses (p < 0.05), this
protective effect was lost in rde-3 animals (p > 0.05) (Figure 6G).
Collectively, our results suggest that VSV infection of adult ani-
mals can lead to a heritable antiviral response that is dependent
upon RDE-3 function.
DISCUSSION
The advantages of using VSV-dsRED microinjection for viral
studies in C. elegans are that it allows the direct delivery of a
known quantity of virus into an animal as well as the ability to
score for infection and tissue involvement in real time. The infec-
tion of RNAi-deficient mutants has revealed the ability of VSV to
replicate not only in muscle tissue (as in N2 infections) but also in
various tissues throughout the animal. The muscle-tropic nature
of N2 infections was surprising given that in mouse models, VSV
is typically neurotropic, although other tissues, includingmuscle,
can become involved [19]. VSV neurotropism in mice might
reflect tissue-specific differences in antiviral responses [19],
and so it is possible that in C. elegans, muscle tissue antiviral re-
sponses may be less robust than in other tissues.
Although previous studies have reported enhanced nodavirus
replication in animals defective for RNAi pathway componentsFigure 6. Prior Exposure of Parental Animals to Virus Infection
Confers Protective Immunity to Their Progeny that Is Dependent
on RDE-3
(A) Percentage of progeny animals collected from mock- (V+V) or VSV-
dsRED-infected (+V+V) mothers displaying dsRED signal 96 hpi with 103 PFU
of VSV-dsRED.
(B) Percentage of N2 or drh-1 progeny animals collected frommock- (V+V) or
VSV-dsRED-infected (+V+V) mothers displaying dsRED signal 72 hpi with
104 PFU of VSV-dsRED.
(C) DIC and fluorescence micrographs (103 magnification) of N2 or rde-3
adults infected with 104 PFU of VSV-dsRED. Images were taken 72 hpi.
(D) Percentage of animals displaying dsRED signal at the indicated times post-
infection with 104 PFU of VSV-dsRED.
(E) Percentage of animals from (D) alive at the indicated times post-infection.
(F) Percentage of N2 or rde-3 animals displaying dsRED signal at 72 hpi after
challenge with the indicated doses of VSV-dsRED.
(G) Percentage of N2 or rde-3 progeny animals collected frommock- (V+V) or
VSV-dsRED-infected (+V+V) mothers displaying dsRED signal 72 hpi after
challenge with either 102 or 104 PFU of VSV-dsRED.
All quantitative experiments used 20–30 animals/treatment and data in bar
graphs represent means (±SEM). Where statistical analyses were performed,
asterisks indicate treatments that are significantly different (p < 0.05) from
control (V+V) treatments. NS, not significant.
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such asDRH-1 [9, 13], RDE-1 [14], and RDE-4 [14], it was unclear
whether these factors contributed to the restriction of negative-
sense ssRNA virus infection in vivo. A mammalian homolog of
DRH-1, RIG-I, is required to initiate an interferon response to
VSV infection in vertebrates [38]. The enhanced susceptibility
of drh-1 animals to VSV suggests that DRH-1 may act in an anal-
ogous manner but instead initiate an antiviral response through
the RNAi pathway. Our examination of small RNA responses in
VSV-infected nematodes revealed a clear reduction in antisense
22Gs targeting VSV in drh-1 mutants compared to N2 animals.
A reduction in antisense 22Gs has also been described during
OV infection of drh-1 animals, suggesting that small RNAs tar-
geting viral transcripts contribute significantly to the restriction
of virus replication [9]. Interestingly, in both N2 and drh-1 animals
there were clear ‘‘hotspots’’ of small RNAsmapping to the 50 end
of the VSV genome. This has also been observed during small
RNA responses against VSV in Drosophila, and has been attrib-
uted to the presence of self-complementary snapback defective
interfering particles derived from the 50 end of the genome [39].
Curiously, although Drosophila Dicer proteins cleave these VSV
snapback particles, the resulting siRNAs are, for unknown rea-
sons, not loaded into Argonautes [39]. It has been postulated
that these interfering particles may serve as an RNA decoy,
allowing VSV evasion of RNAi machinery [39, 40]. It will be inter-
esting to determine whether VSV produces defective interfering
particles in C. elegans and whether small RNAs targeting these
particles are loaded into RDE-1.
Although SID-1 is required for the systemic spread of exoge-
nous RNAi signals [28], sid-1 mutants were as susceptible to
VSV as N2 animals. This is consistent with previous virus studies
in C. elegans [3, 33]. Whether another, unidentified, RNA trans-
porter is required for mounting systemic RNAi responses to
infection is unknown.
Interestingly, we found that VSV could infect the germline of
drh-1 animals and be vertically transmitted when somatically
injected animals were placed on FUdR-containing plates. How
this DNA synthesis inhibitor might compromise germline immu-
nity to infection is unknown. However, FUdR treatment can
modulate resistance to thermal, hypertonic, and proteotoxic
stresses, most likely through alteration of gene expression [40].
Therefore, FUdR-induced inhibition of germline gene expression
programs and/or stress responses that normally serve antiviral
roles may promote germline infection and vertical transmission.
However, because VSV could efficiently establish germline
infection after direct injection into the germline in the absence
of FUdR, these drug-induced effects may only be required to
sensitize the germline to infection as the virus spreads from
the soma. Direct injection of VSV into the germline may simply
overwhelm germline antiviral responses, even without modula-
tion by FUdR treatment. Importantly, no evidence was found
for vertical transmission of other intracellular C. elegans patho-
gens such as microsporida [41] and OV [14]. Therefore, our
model provides new opportunities to study vertical transmission
in C. elegans.
Previous reports have demonstrated that administration of a
mild stress (e.g., temporary starvation) to C. elegans can lead
to enhanced protection of offspring from these same stressors,
a phenomenon termed ‘‘transgenerational hormesis’’ [42, 43].
In some cases, this phenomenon can be mediated by small
RNAs [43]. A previous report found transgenerational silencing
of a flock house virus transgene [34], and Sterken et al. [35] re-
ported that OV-infected N2, but not RNAi-deficient, animals
could transmit a heritable, protective antiviral response to their
progeny. In contrast, Ashe et al. [33] did not find evidence for
transgenerational immunity after OV infection. We found that
prior exposure of N2 or drh-1 animals to VSV led to significant re-
ductions in the infection rates of their progeny when challenged
with VSV.Wewere initially surprised by the inheritance of an anti-
viral response in drh-1 animals, which is in contradiction with
Sterken et al. [35]. However, because antiviral small RNA pro-
duction in drh-1 animals was reduced, but not eliminated, it is
possible that these residual small RNAs may still confer protec-
tion to offspring. We attempted to detect small RNAs targeting
VSV in the progeny from naive or VSV-exposed mothers but
were unable to observe significant quantities of viral small
RNAs in these deep-sequencing experiments. It is unclear
whether viral small RNAs exist in progeny animals at too low a
level for detection by our methods or whether the heritable anti-
viral effect is not mediated by small RNAs. We favor the former
scenario, as rde-3 animals are completely defective in 22G
biogenesis [37], and we found no evidence for transgenerational
antiviral immunity in rde-3 animals. The ability of C. elegans to
use a heritable antiviral response to protect offspring from infec-
tion represents a fascinating adaptation that warrants further
investigation.
The susceptibility of C. elegans to VSV provides a genetically
tractable in vivo model system to explore negative-sense ssRNA
virus biology and antiviral immunity. Our system will nicely com-
plement in vivo models that have been established for VSV in
Drosophila and mice [19], giving investigators the rare opportu-
nity to study a single virus in disparate hosts.
EXPERIMENTAL PROCEDURES
Cell, Virus, and Worm Culture
Baby hamster kidney (BHK) and BSC-40 cells (American Type Culture Collec-
tion) were cultured as described [24] in Dulbecco’s modified Eagle’s medium
(DMEM; Invitrogen). VSV stocks were prepared as described [24] and resus-
pended in DMEM. Viral and nematode strains used in the study are described
in the Supplemental Experimental Procedures. Unless otherwise indicated,
NGM plates were incubated at 25C for the duration of experiments.
Microinjections
Microinjections used young adults and pulled capillary needles secured onto a
Nikon TE200 microscope equipped with a micromanipulator and regulated
pressure source. Needles containing either DMEM (mock infections) or virus
resuspended in DMEM were used for microinjections. Doses of VSV (in PFU)
represent estimates based on VSV titration of BSC-40 cells and a dispensed
volume of 10 nL during microinjections. Injected worms were immediately
placed on NGM plates seeded with OP50 Escherichia coli. Where indicated,
NGM also contained 50 mg/mL FUdR (Sigma).
RNA Isolation and RT-PCR
Total RNA was purified from adult worms or embryos at the indicated times as
described [44]. VSV (+)-sense transcription and C. elegans actin gene tran-
scription were analyzed by RT-PCR as described [24].
Immunoblotting
Antibodies used for immunoblotting included mouse anti-LUC (Invitrogen),
rabbit anti-actin (Abcam), and mouse anti-VSV Matrix (Douglas Lyles, Wake
Forest School of Medicine). Immunoblots were performed as described [24].
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Lifespan, LUC, and Transgenerational Immunity Assays,
Microscopy, and Small RNA Cloning and Analysis
See the Supplemental Experimental Procedures for details.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
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